Top Performing Atrial Fibrillation Drugs in the US
HealthPals’ CLINT engine was used to analyze the ACC PINNACLE® Registry and summarize the current state of stroke prevention strategies in patients with atrial fibrillation. This white paper covers the existent care gaps in oral anticoagulant usage, the effect geographic location can have on practice adherence, and insights including:
Highlighting the difficulty in following guideline-indicated treatments in cardiovascular diseases by listing overall care gap percentages for atrial fibrillation, diabetes, antihypertensive drugs and statins.
Looking at market performance of the most utilized atrial fibrillation drugs in the US, along with predictions for future performance in light of the recent 2019 AHA/ACC Atrial Fibrillation Guideline Update
Examining a US state-by-state breakdown of atrial fibrillation drug usage and care gap percentage